Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY: CRL )

113.94 -1.82 (-1.57%)
Streaming Delayed Price Updated: 11:41 AM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 299,673
Open 113.85
Bid (Size) 113.78 (2)
Ask (Size) 114.12 (2)
Prev. Close 115.76
Today's Range 112.12 - 115.25
52wk Range 91.86 - 254.15
Shares Outstanding 50,396,622
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Worst Performing Large-Caps Last 12 Months
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga

Performance

YTD
-37.61%
-37.61%
1 Month
-29.38%
-29.38%
3 Month
-31.71%
-31.71%
6 Month
-37.64%
-37.64%
1 Year
-52.41%
-52.41%

More News

Read More
Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
From Charles River Laboratories International, Inc.
Via Business Wire
10 Worst Performing Large-Caps Last 12 Months
Via Talk Markets
Topics Stocks / Equities
The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?
Via MarketBeat
Topics ETFs Economy Government
Exposures Political Supply Chain Tariff
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Wall Street Pulls Back After Early Gains As Tariff Uncertainties Persist: What's Driving Markets Monday?
Via Benzinga
Topics World Trade
Exposures Tariff
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
Via Benzinga
Topics Animal Testing
Exposures Animal Testing Product Safety
Which S&P500 stocks are moving on Friday?
Via Chartmill
Wall Street Rebounds, JPMorgan Jumps On Strong Q1 Earnings: What's Driving Markets Friday?
Via Benzinga
Topics Economy World Trade
Exposures Interest Rates Tariff
FDA’s Intent To Phase Out Animal Testing Requirement Weighs Down Charles River Stock: Retail’s Disheartened
Via Stocktwits
Topics Animal Testing
Exposures Animal Testing Product Safety
What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?
Via Benzinga
Topics Animal Testing Artificial Intelligence
Exposures Animal Testing Artificial Intelligence Product Safety
These S&P500 stocks that are showing activity before the opening bell on Friday.
Via Chartmill
Charles River Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
Via Benzinga
Tuesday's session: top gainers and losers in the S&P500 index
Via Chartmill
What's going on in today's session: S&P500 movers
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
Via Chartmill
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
From Charles River Laboratories International, Inc.
Via Business Wire
Demystifying Charles River: Insights From 10 Analyst Reviews
Via Benzinga
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
Via StockStory
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Top S&P500 movers in Thursday's session
Via Chartmill
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.